Cardiovascular Risk Clinic
Cardiovascular Risk Clinic
This study was a prospective, randomized trial designed to investigate the efficacy of
 moderate lifestyle modification for improving the clinical status of patients with coronary
 artery disease or patients with risk factors that promote coronary artery disease.
The main hypothesis to be tested in the Cardiovascular Risk Clinic was: Can individualized
 therapeutic lifestyle plans in conjunction with molecular analysis lead to informative
 assessments of disease risk that can reduce risk factors for diabetes and cardiovascular
 disease.

 Our main objectives were:

 A. To investigate the effect of lifestyle modification on: (1) physiological measurements of
 coronary artery disease (CAD) including carotid intima-media thickness (CIMT), exercise
 stress tests, blood pressure, body mass index (BMI), and weight; (2) plasma markers
 associated with development of CAD such as lipids and triglycerides; and (3) molecular
 characteristics such as gene expression signatures and protein profiles.

 B. To determine if patients with heart disease or risk factors that would promote heart
 disease can achieve and adhere to the goals of a lifestyle change program in a
 non-residential, out-patient setting.
Inclusion Criteria: at least one known risk factor for cardiovascular disease:

 -  Family history of CAD (first degree relative)

 -  Physician-diagnosed diabetes or stroke

 -  Overweight (BMI/=25) or obese (BMI>/=30)

 -  Total cholesterol >/=200, documented history of hypercholesterolemia, or currently
 taking lipid lowering medications

 -  History of smoking

 -  HDL </=44 mg/dl

 -  LDL >/=130 mg/dl or documented history of hyperlipidemia

 -  Elevated triglycerides (>/=200 mg/dl)

 -  Hypertension (systolic blood pressure >/=130 mmHg, diastolic blood pressure >/=85
 mmHg, documented diagnosis of hypertension, or currently taking antihypertensive
 medications)

 -  Diabetes (fasting glucose >/=100 mg/dl, physician diagnosis of diabetes/pre-diabetes,
 or currently taking anti-glycemic medications)

 -  Post traumatic stress disorder (PTSD) or at risk for PTSD

 -  Insomnia (five hours of sleep per night or less) or sleep apnea

 Exclusion Criteria:

 -  Age <18 years of age

 -  Unstable coronary syndromes, refractory congestive heart failure, uncontrolled
 arrhythmia, or high-grade uncorrected cardiac conduction abnormalities

 -  Any contraindication to components to Program, such as physical disabilities
 precluding stretching and aerobic exercise or medical conditions that preclude
 consumption of foods essential to Program diet

 -  Inability or unwillingness to give consent

 -  Significant left main stenosis (>50%) or ejection fraction <35% with no
 revascularization

 -  History of substance abuse (including alcohol) without self-certification of
 abstinence for at least three months

 -  Non-ambulatory (bedridden) individuals